Cargando…

Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India

Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the proportion of deaths during MDR TB treatment attributable to TB itself. We used a structured verba...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Poonam Ramesh, Moonan, Patrick K., Nirgude, Abhay Subhashrao, Shewade, Hemant Deepak, Satyanarayana, Srinath, Raghuveer, Pracheth, Parmar, Malik, Ravichandra, Chinnappareddy, Singarajipura, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823351/
https://www.ncbi.nlm.nih.gov/pubmed/29460737
http://dx.doi.org/10.3201/eid2403.171718
_version_ 1783301860740825088
author Naik, Poonam Ramesh
Moonan, Patrick K.
Nirgude, Abhay Subhashrao
Shewade, Hemant Deepak
Satyanarayana, Srinath
Raghuveer, Pracheth
Parmar, Malik
Ravichandra, Chinnappareddy
Singarajipura, Anil
author_facet Naik, Poonam Ramesh
Moonan, Patrick K.
Nirgude, Abhay Subhashrao
Shewade, Hemant Deepak
Satyanarayana, Srinath
Raghuveer, Pracheth
Parmar, Malik
Ravichandra, Chinnappareddy
Singarajipura, Anil
author_sort Naik, Poonam Ramesh
collection PubMed
description Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the proportion of deaths during MDR TB treatment attributable to TB itself. We used a structured verbal autopsy tool to interview family members of patients who died during MDR TB treatment in India during January–December 2016. A committee triangulated information from verbal autopsy, death certificate, or other medical records available with the family members to ascertain the underlying cause of death. For 66% of patient deaths (47/71), TB was the underlying cause of death. We assigned TB as the underlying cause of death for an additional 6 patients who died of suicide and 2 of pulmonary embolism. Deaths during TB treatment signify program failure; accurately determining the cause of death is the first step to designing appropriate, timely interventions to prevent premature deaths.
format Online
Article
Text
id pubmed-5823351
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-58233512018-03-01 Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India Naik, Poonam Ramesh Moonan, Patrick K. Nirgude, Abhay Subhashrao Shewade, Hemant Deepak Satyanarayana, Srinath Raghuveer, Pracheth Parmar, Malik Ravichandra, Chinnappareddy Singarajipura, Anil Emerg Infect Dis Research Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the proportion of deaths during MDR TB treatment attributable to TB itself. We used a structured verbal autopsy tool to interview family members of patients who died during MDR TB treatment in India during January–December 2016. A committee triangulated information from verbal autopsy, death certificate, or other medical records available with the family members to ascertain the underlying cause of death. For 66% of patient deaths (47/71), TB was the underlying cause of death. We assigned TB as the underlying cause of death for an additional 6 patients who died of suicide and 2 of pulmonary embolism. Deaths during TB treatment signify program failure; accurately determining the cause of death is the first step to designing appropriate, timely interventions to prevent premature deaths. Centers for Disease Control and Prevention 2018-03 /pmc/articles/PMC5823351/ /pubmed/29460737 http://dx.doi.org/10.3201/eid2403.171718 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Naik, Poonam Ramesh
Moonan, Patrick K.
Nirgude, Abhay Subhashrao
Shewade, Hemant Deepak
Satyanarayana, Srinath
Raghuveer, Pracheth
Parmar, Malik
Ravichandra, Chinnappareddy
Singarajipura, Anil
Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
title Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
title_full Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
title_fullStr Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
title_full_unstemmed Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
title_short Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
title_sort use of verbal autopsy to determine underlying cause of death during treatment of multidrug-resistant tuberculosis, india
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823351/
https://www.ncbi.nlm.nih.gov/pubmed/29460737
http://dx.doi.org/10.3201/eid2403.171718
work_keys_str_mv AT naikpoonamramesh useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT moonanpatrickk useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT nirgudeabhaysubhashrao useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT shewadehemantdeepak useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT satyanarayanasrinath useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT raghuveerpracheth useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT parmarmalik useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT ravichandrachinnappareddy useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia
AT singarajipuraanil useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia